Increased Demand for Non-Invasive Surgical Procedures to Control Uterine Bleeding Spurs Need for Endometrial Ablation

Endometrial ablation is a surgical procedure involving the removal or destruction of the endometrium—lining of the uterus—along with the superficial myometrium. Over the past few years, it has emerged as a preferred alternative to hysterectomy for women with excessive uterine bleeding and to control the condition of heavy menstrual bleeding (HMB). Also called menorrhagia, HMB is primarily caused due to uterine fibroids, uterine polyps, or endometriosis. Among adolescents, it may be due to hormonal imbalance, particularly in estrogen and progesterone levels, whereas gynecologic malignancy may lead to HMB in premenopausal women. 

In instances where medical therapies have failed or women do not prefer hormone modifying drug therapies, endometrial ablation has emerged as a popular procedure. Older women seeking to avoid hormonal imbalance to keep their reproductive functions intact may adopt endometrial ablation. This is an outpatient procedure usually carried out using a hysteroscopy or resectoscope and is considered to be a safe and minimally-invasive procedure. 

According to a projection by Transparency Market Research, the global market for endometrial ablation is anticipated to rise at a healthy CAGR of 5.50% during 2016–2024 and is estimated to attain US$1.3 bn by the end of 2024. 

What are the factors boosting the demand for endometrial ablation? 

The surgery has gained popularity over the years since it is considered safe and non-invasive, offers less post-surgery complications, and has a higher success rate compared to other treatments. Shorter hospital stay and cost-efficiency of the procedure are factors stimulating the demand for endometrial ablation techniques.

The wide prevalence of gynecological disorders, such as HMB and polycystic ovarian disease (PCOD), and the rising incidence of cervical and endometrial cancer have led to an increased demand for endometrial ablation worldwide. Among the various devices used for endometrial ablation, radiofrequency endometrial ablation devices are expected to lead the market. The factors propelling the significant adoption of the endometrial ablation procedure consist of enhanced convenience of usage, low-cost benefits, and shorter time of surgery. 


However, the presence of a stringent regulatory regime for approval of devices, lack of robust policies for clinical trials, and low commercialization of devices may impede the growth of the market to an extent. On the other hand, technological advancements in endometrial devices that enhance patient satisfaction have opened up lucrative opportunities for market players. Several manufacturers and vendors are offering controlled, customized, and contoured endometrial devices to reap significant competitive benefits.

Which regions are expected to bolster the uptake of endometrial ablation devices? 

The major regions in the global endometrial ablation market comprise Europe, North America, Latin America, the Middle East and Africa, and Asia Pacific. North America is the dominant market for endometrial ablation and is expected to lead along the forecast period. The growth is attributed to a robust healthcare infrastructure and increased access to healthcare facilities; the regional market is expected to account for a major market share of around 44% by 2024.

Asia Pacific is expected to provide enormous opportunities to market players over the next few years. The increasing prevalence of gynecological disorders and various technological advancements in endometrial devices have propelled the regional market. 

0 comments:

Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports